Manifestations endocriniennes liées au sepsis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Réanimation

• Publication date

  2005-06-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.REAURG.2005.04.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stress-hyperglycemia, insulin and immunomodulation in sepsis

  2004cited by this paper
• Measurements of serum free cortisol in critically ill patients.

  2004cited by this paper
• Corticosteroid insufficiency in acutely ill patients.

  2003cited by this paper
• Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.

  2003cited by this paper
• High-dose vasopressin is not superior to norepinephrine in septic shock*

  2003cited by this paper
• Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

  2003cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2003cited by this paper
• Circulating vasopressin levels in septic shock.

  2003cited by this paper
• Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression.

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Terlipressin for norepinephrine-resistant septic shock.

  2002cited by this paper
• Depletion of neurohypophyseal content of vasopressin in septic shock.

  2002cited by this paper
• Treatment preferences of seriously ill patients.

  2002cited by this paper
• Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.

  2002cited by this paper
• Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells.

  2002cited by this paper
• Alterations in fuel metabolism in critical illness: hyperglycaemia.

  2001cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

  2001cited by this paper
• Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery.

  2001cited by this paper
• Physiology of vasopressin relevant to management of septic shock.

  2001cited by this paper
• Mechanisms of Tissue Injury in Sepsis: Contrasts between Gram Positive and Gram Negative Infection

  2001cited by this paper
• Is insulin an antiinflammatory molecule?

  2001cited by this paper
• Alterations in glucose-6-phosphatase gene expression in sepsis.

  2000cited by this paper
• A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

  2000cited by this paper
• Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome

  1999cited by this paper
• Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.

  1999cited by this paper
• Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.

  1998cited by this paper
• Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way?

  1998cited by this paper
• Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients.

  1998cited by this paper
• Corticotropin‐Releasing Hormone and Inflammation

  1998cited by this paper
• Sepsis: a new hypothesis for pathogenesis of the disease process.

  1997cited by this paper
• Role of vasopressin deficiency in the vasodilation of septic shock.

  1997cited by this paper
• Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness.

  1997cited by this paper
• Euthyroid Sick Syndrome: Is It a Misnomer?

  1997cited by this paper
• Vasopressin pressor hypersensitivity in vasodilatory septic shock.

  1997cited by this paper
• Local venous responses to endotoxin in humans.

  1996cited by this paper
• Human adrenal cells express tumor necrosis factor-alpha messenger ribonucleic acid: evidence for paracrine control of adrenal function.

  1996cited by this paper
• Insulin action and the insulin signaling network.

  1995cited by this paper
• The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

  1995cited by this paper
• Corticosteroid effect on early beta-adrenergic down-regulation durign circulatory shock: Hemodynamic study and beta-adrenergic receptor assay

  1995cited by this paper
• Cytokines as mediators of chronic asthma.

  1994cited by this paper
• Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function.

  1994cited by this paper
• Impaired β‐adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines

  1993cited by this paper
• Effects of Recombinant Human Growth Hormone in Patients With Severe Sepsis

  1992cited by this paper
• Plasma cortisol levels in patients with septic shock.

  1991cited by this paper
• Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

  1990cited by this paper
• Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells.

  1988cited by this paper
• Effect of severe burn injury on substrate cycling by glucose and fatty acids.

  1987cited by this paper
• The dissociation of renin and aldosterone during critical illness.

  1987cited by this paper
• Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages.

  1985cited by this paper
• Evidence and Quantification of the Vasopressin Arterial Pressure Control System in the Dog

  1980cited by this paper

• Impact of non-severe infections on cortisol and thyroid stimulating hormone baseline levels in hospitalized patients: A monocentric cross-sectional study

  2024cites this paper
• Utilisation rationnelle des émulsions parentérales dans un Service de soins intensifs adulte

  2015cites this paper
• Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness

  2012cites this paper
• [Is free plasmatic cortisol measurement useful in intensive care unit?].

  2008cites this paper
• Le coma myxoedémateux existe, nous l'avons rencontré

  2007cites this paper